Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02558673 · ClinicalTrials.gov registry record · NA
Trimethylamine-N-oxide Production and Metabolism
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02558673 is a NA study that has completed, run by Cornell University. The registered enrollment target is 40 participants.
The verdict
NCT02558673, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study was to understand the production of trimethylamine-N-oxide (TMAO) and its metabolites from dietary precursors found in fish, eggs and beef. In addition, this study traced the fate of supplemental TMAO that has been labeled with deuterium to determine how TMAO is being used in the body.
Interventions
- OTHER TMAO dietary precursors
- OTHER Control (or active comparator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02558673
The ClinicalTrials.gov registry entry for NCT02558673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TMAO dietary precursors is the first listed.
NCT02558673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02558673 about?
NCT02558673 is a clinical study titled "Trimethylamine-N-oxide Production and Metabolism". The purpose of this study was to understand the production of trimethylamine-N-oxide (TMAO) and its metabolites from dietary precursors found in fish, eggs and beef. In addition, this study traced the fate of supplemental TMAO that has been labeled with deuterium to determine how TMAO is being used ...
What is the current status of trial NCT02558673?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-05. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02558673?
The interventions under investigation include: TMAO dietary precursors (OTHER), Control (or active comparator) (OTHER).
Who is sponsoring clinical trial NCT02558673?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.